下肢关节置换术后谵妄的危险因素:回顾性人群队列研究
基于美国Premier医疗数据库2006—2016年1 694 795例择期全髋/膝关节置换患者的回顾性队列显示,术后谵妄发生率髋置换为2.6%、膝置换为2.9%。长效苯二氮䓬类、长短效联合苯二氮䓬类和加巴喷丁类药物与谵妄风险升高相关;椎管内麻醉对比全麻、使用NSAIDs或COX-2抑制剂与风险降低相关。
要点
- 长效苯二氮䓬类(OR 2.10)和加巴喷丁类药物(OR 1.26)与术后谵妄风险升高相关。
- 椎管内麻醉对比全麻(OR 0.81)、NSAIDs(OR 0.85)和COX-2抑制剂(OR 0.82)与谵妄风险降低相关。
- >65岁患者中高剂量对比低剂量阿片类药物与谵妄风险降低相关(OR 0.86)。
核心结论
- 在大型全国队列中识别出多种可改变的术后谵妄危险因素,包括麻醉类型和药物使用,提示可能的预防路径。
研究设计与样本
- 回顾性人群队列研究,使用Premier Healthcare数据库2006—2016年择期全髋/膝关节置换患者,共1 694 795例。
主要发现
- 术后谵妄发生率髋置换为2.6%(14 785/564 226),膝置换为2.9%(32 384/1 130 569)。
- 长效苯二氮䓬类(OR 2.10,95%CI 1.82–2.42)、长短效联合苯二氮䓬类(OR 1.74,95%CI 1.56–1.94)和加巴喷丁类药物(OR 1.26,95%CI 1.16–1.36)与谵妄风险升高相关。
- 椎管内麻醉对比全麻(OR 0.81,95%CI 0.70–0.93)、NSAIDs(OR 0.85,95%CI 0.79–0.91)和COX-2抑制剂(OR 0.82,95%CI 0.77–0.89)与谵妄风险降低相关。
- 年龄分层分析显示>65岁患者中高剂量对比低剂量阿片类药物与谵妄风险降低相关(OR 0.86,95%CI 0.76–0.98)。
- 髋与膝关节置换结果一致。
临床怎么用
- 关节置换围术期应审慎使用长效苯二氮䓬类和加巴喷丁类药物以降低谵妄风险。
- 在适用情况下可优先考虑椎管内麻醉及NSAIDs/COX-2抑制剂作为谵妄风险较低的策略。
局限性
- 回顾性研究设计,基于行政索赔数据,可能存在编码偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With an ageing population, the demand for joint arthroplasties and the burden of postoperative delirium is likely to increase. Given the lack of large-scale data, we investigated associations between perioperative risk factors and postoperative delirium in arthroplasty surgery. METHODS: This retrospective population-based cohort study, utilized national claims data from the all-payer Premier Healthcare database containing detailed billing information from >25% nationwide hospitalizations. Patients undergoing elective total hip/knee arthroplasty surgery (2006-2016) were included.The primary outcome was postoperative delirium, while potential risk factors included age, gender, race, insurance type, and modifiable exposures including anesthesia type, opioid prescription dose (low/medium/high), benzodiazepines, meperidine, non-benzodiazepine hypnotics, ketamine, corticosteroids, and gabapentinoids. RESULTS: Among 1 694 795 patients' postoperative delirium was seen in 2.6% (14 785/564 226) of hip and 2.9% (32 384/1 130 569) of knee arthroplasties. Multivariable models revealed that the utilization of long acting (OR 2.10 CI 1.82 to 2.42), combined long/short acting benzodiazepines (OR 1.74 CI 1.56 to 1.94), and gabapentinoids (OR 1.26 CI 1.16 to 1.36) was associated with increased odds of postoperative delirium. Lower odds of postoperative delirium were seen for neuraxial versus general anesthesia (OR 0.81 CI 0.70 to 0.93) and with the utilization of non-steroidal anti-inflammatory drugs (OR 0.85 CI 0.79 to 0.91) as well as cyclooxygenase-2 inhibitors (OR 0.82 CI 0.77 to 0.89). Age-stratified analysis revealed lower odds with high versus low opioid dose (OR 0.86 CI 0.76 to 0.98) in patients >65 years. Findings were consistent between hip and knee arthroplasties. CONCLUSIONS: In this large national cohort, we identified various modifiable risk factors (including anesthesia type and pharmaceutical agents) for postoperative delirium, demonstrating possible prevention pathways.
引用
- Memtsoudis S, Cozowicz C, Zubizarreta N, et al. Risk factors for postoperative delirium in patients undergoing lower extremity joint arthroplasty: a retrospective population-based cohort study. Reg Anesth Pain Med. 2019. PMID: 31302641. doi:10.1136/rapm-2019-100700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。